Overview
No overview information available.
Indication
No indication information available.
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|
No clinical trials found
No clinical trials found for this drug
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| Multizyme | 350976 | Medicine | A | 12/7/2020 | |
| Plexus ProBioFit | 353839 | Medicine | A | 1/29/2021 | |
| ProBioFit | 483565 | Medicine | A | 3/21/2025 | |
| Bloating Relief | 486010 | Medicine | A | 4/14/2025 | |
| Executive Digestive | 351741 | Medicine | A | 12/15/2020 | |
| Bioglan Platinum Digest Eze | 423692 | Medicine | A | 10/3/2023 | |
| PM Essentials | 342492 | Regulatory Services Australia | Medicine | A | 8/27/2020 |
| Fit Solution Cell Nutrition | 326722 | Medicine | A | 11/26/2019 | |
| BN Enzyme Plus | 393853 | Medicine | A | 8/12/2022 | |
| METAGENICS VEGETARIAN DIGESTIVE ENZYMES | 353138 | Medicine | A | 1/15/2021 |
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| THERAPY FORMULAS MULTI-ENZYME FORMULA-CAP | general nutrition canada inc. | 02216736 | Capsule - Oral | 50 MG | 10/15/2001 |
| METAZYME CAP | 00837059 | Capsule - Oral | 200 UNIT / CAP | 12/29/1996 | |
| MEALZYME | regime industries ltd. | 02242743 | Capsule - Oral | 25 MG | 12/19/2001 |
| ENZYME FORMULA DIGESTION AID | rx vitamins inc. | 02239302 | Capsule - Oral | 25 MG | 3/1/2004 |
| NU-ZYMES | media power, inc. | 02246909 | Capsule - Oral | 50 UNIT | 11/23/2002 |
| DIGESTION FORMULA - CAP | prevail corporation | 02184885 | Capsule - Oral | 15 MG | 4/1/1999 |
| SUPER PAYA JAY TAB | jamieson laboratories ltd | 00504637 | Tablet - Oral | .75 MG / TAB | 12/31/1981 |
| COTAZYM 65B | Merck Canada Inc | 00456233 | Capsule - Oral | 2 MG | 12/31/1979 |
| PAPAYA ZYME TAB NU LIFE | nu-life nutrition ltd. | 00397822 | Tablet - Oral | 5 MG | 12/31/1977 |
| MULTI-ENZYME | sisu inc. | 02237954 | Capsule - Oral | 30 UNIT | 6/29/1998 |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| No CIMA AEMPS (Spain) approvals found for this drug. | |||||
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.